Cohort information

FRANCE WP2
Organization INSERM
Name of cohort French COVID-19
Referring partner INSERM
Cohort Information Country(-ies), cities, regions or centers involved France
Time of data collection 02/2020 Ongoing
Enrolment Inactive
Study setting Multi-centers
Population Age Children,Adolescents,Adults,Elderly
Type Both
Total number of patients 4572
Site of enrolment (WP2) Inpatient,ICU
Data collection Clinical data True
Serological data True
Genetic data True
Sample collection True
Sample collected Whole blood No
PBMC Yes
Dry-spot blood No
Plasma Yes
Serum Yes
Stool Yes
NP swabs Yes
Other None
Description The objectives of this cohort are to describe: 1) clinical features of illness; 2) treatment used and their outcome; 3) virus replication, excretion and evolution in multiple sites; 4) host responses including innate and acquired immune responses; 5) host genetic variants associated with disease progression/severity.
Publications - Determinants of anti-S immune response at 6 months after COVID-19 vaccination in a multicentric European cohort of healthcare workers – ORCHESTRA project [Frontiers in Immunology]
- SARS-CoV-2 Breakthrough Infections in Health Care Workers: An Italian Retrospective Cohort Study on Characteristics, Clinical Course and Outcomes [Journal of Clinical Medicine]